Genetic and morphologic characteristics of AML patient samples used for microRNA-34a analysis and Western blot analysis
Patient no. . | Morphology by FAB . | % blasts in bone marrow . | Karyotype . | CEBPA mutation status . | Age (y) . | WBC count (109/L) . | FLT3 mutation status . |
---|---|---|---|---|---|---|---|
1 | M1 | 95 | Normal | Nil | 70 | 12.3 | Positive |
2 | M2 | 60 | Normal | Nil | 60 | 1.8 | Negative |
3 | M4 | 80 | Normal | Nil | 79 | 27.0 | Negative |
4 | M5 | 95 | Normal | Nil | 35 | 174.5 | Positive |
5 | M4 | 90 | Normal | Double | 45 | 105.0 | Negative |
6 | M2 | 85 | Normal | Double | 64 | 759.0 | Positive |
7 | M2 | 90 | Normal | Double | 63 | 308.0 | Negative |
8 | M4 | 55 | del(12)(p11p12), t(17;18) (q24;, q11)[20] | Single | 35 | 16.4 | Negative |
9 | M2 | 55 | Normal | Double | 56 | 60.9 | Negative |
10 | M1 | 81 | Normal | Double | 12 | 29.5 | Negative |
11 | M2 | 65 | Normal | Double | 16 | 9.1 | Negative |
12 | M2 | 72 | Normal | Single | 51 | 45.0 | Negative |
13 | Unclassified | 86 | Normal | Double | 9 | 37.3 | Negative |
14 | M2 | 47 | Normal | Double | 6 | 19.8 | Negative |
15 | M2 | 81 | Normal | Double | 5 | 23.4 | Negative |
16 | M1 | 94 | Normal | Double | 12 | 160.6 | Negative |
17 | M4 | 58 | Normal | Double | 14 | 122.7 | Negative |
18 | M1 | 70 | Normal | Double | 11 | 20.4 | Negative |
19 | Unknown | Unknown | Normal | Double | 34 | 32.0 | Positive |
20 | M2 | 85 | Normal | Double | 48 | 72.0 | Negative |
21 | M1 | 85 | Normal | Double | 61 | 20.1 | Negative |
22 | M2 | 58 | Normal | Single | 72 | 4.9 | Negative |
23 | M1 | Unknown | Normal | Single | 73 | 34.3 | Positive |
24 | M2 | 72 | Normal | Single | 51 | 45.0 | Negative |
25 | M2 | 49 | Normal | Double | 31 | 4.3 | Negative |
Patient no. . | Morphology by FAB . | % blasts in bone marrow . | Karyotype . | CEBPA mutation status . | Age (y) . | WBC count (109/L) . | FLT3 mutation status . |
---|---|---|---|---|---|---|---|
1 | M1 | 95 | Normal | Nil | 70 | 12.3 | Positive |
2 | M2 | 60 | Normal | Nil | 60 | 1.8 | Negative |
3 | M4 | 80 | Normal | Nil | 79 | 27.0 | Negative |
4 | M5 | 95 | Normal | Nil | 35 | 174.5 | Positive |
5 | M4 | 90 | Normal | Double | 45 | 105.0 | Negative |
6 | M2 | 85 | Normal | Double | 64 | 759.0 | Positive |
7 | M2 | 90 | Normal | Double | 63 | 308.0 | Negative |
8 | M4 | 55 | del(12)(p11p12), t(17;18) (q24;, q11)[20] | Single | 35 | 16.4 | Negative |
9 | M2 | 55 | Normal | Double | 56 | 60.9 | Negative |
10 | M1 | 81 | Normal | Double | 12 | 29.5 | Negative |
11 | M2 | 65 | Normal | Double | 16 | 9.1 | Negative |
12 | M2 | 72 | Normal | Single | 51 | 45.0 | Negative |
13 | Unclassified | 86 | Normal | Double | 9 | 37.3 | Negative |
14 | M2 | 47 | Normal | Double | 6 | 19.8 | Negative |
15 | M2 | 81 | Normal | Double | 5 | 23.4 | Negative |
16 | M1 | 94 | Normal | Double | 12 | 160.6 | Negative |
17 | M4 | 58 | Normal | Double | 14 | 122.7 | Negative |
18 | M1 | 70 | Normal | Double | 11 | 20.4 | Negative |
19 | Unknown | Unknown | Normal | Double | 34 | 32.0 | Positive |
20 | M2 | 85 | Normal | Double | 48 | 72.0 | Negative |
21 | M1 | 85 | Normal | Double | 61 | 20.1 | Negative |
22 | M2 | 58 | Normal | Single | 72 | 4.9 | Negative |
23 | M1 | Unknown | Normal | Single | 73 | 34.3 | Positive |
24 | M2 | 72 | Normal | Single | 51 | 45.0 | Negative |
25 | M2 | 49 | Normal | Double | 31 | 4.3 | Negative |
FAB indicates French-American-British; and WBC, white blood count.